Lumbar 3-Lumbar 5 Robotic-Assisted Endoscopic Transforaminal Lumbar Interbody Fusion: 2-Dimensional Operative Video.

Endoscopy Lumbar Minimally invasive surgery Robotic arm Transforaminal lumbar interbody fusion

Journal

Operative neurosurgery (Hagerstown, Md.)
ISSN: 2332-4260
Titre abrégé: Oper Neurosurg (Hagerstown)
Pays: United States
ID NLM: 101635417

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 15 07 2019
accepted: 13 10 2019
pubmed: 8 12 2019
medline: 22 6 2021
entrez: 8 12 2019
Statut: ppublish

Résumé

Minimally invasive spine surgery has the potential to reduce soft tissue destruction, blood loss, postoperative pain, and overall perioperative morbidity while accelerating recovery. Robotic guidance systems are relatively new tools in the minimally invasive surgeon's armamentarium, striving to increase accuracy of instrumentation placement, decrease complications, reduce radiation burden, and enhance surgical ergonomics in order to improve efficiency and maximize patient outcomes. We present the case of a 78-yr-old male with intractable lower back and bilateral lower extremity pain with multilevel degenerative spondylosis. The procedure performed was a L3-5 robotic-assisted endoscopic transforaminal lumbar interbody fusion (TLIF) utilizing the Mazor X robotic guidance system (Medtronic) for both percutaneous pedicle screw placement, as well as trajectory localization for endoscopic discectomy and percutaneous interbody delivery. Previously, clinical and radiographic success has been published regarding the awake, endoscopic TLIF.1 We document the first use of robotic guidance for disc space localization and its combination with endoscopy to achieve interbody fusion, utilizing an expandable, allograft-filled mesh interbody device.2 This video demonstrates appropriate patient positioning, work flow for this unique technique, and the benefits of using robotic guidance to plan and execute percutaneous trajectories through Kambin's triangle. This procedure involves the off-label use of recombinant human bone morphogenetic protein-2 (Infuse™, Medtronic), OptiMesh® graft containment device (Spineology), and liposomal bupivacaine (Exparel®, Pacira).

Identifiants

pubmed: 31811291
pii: 5666222
doi: 10.1093/ons/opz385
doi:

Types de publication

Case Reports Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

E73-E74

Informations de copyright

Copyright © 2019 by the Congress of Neurological Surgeons.

Auteurs

Jason I Liounakos (JI)

Department of Neurological Surgery, University of Miami, Miami, Florida.

Michael Y Wang (MY)

Department of Neurological Surgery, University of Miami, Miami, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH